Red Light Therapy

Red Light Therapy for Autism

Photobiomodulation (PBM) is an emerging, non-invasive therapeutic approach for autism spectrum disorder (ASD). TGA-listed devices. Clinic sessions in Melbourne. At-home options that ship Australia-wide.

TGA Listed Melbourne Clinic Ships Australia-Wide 140+ Five-Star Reviews
The Science

What Does Red Light Therapy Do for the Autistic Brain?

Research into photobiomodulation (PBM) for autism spectrum disorder focuses on three interconnected mechanisms that are all documented features of ASD biology: mitochondrial dysfunction, neuroinflammation, and oxidative stress.

660nm red light stimulates cytochrome c oxidase in the mitochondrial electron transport chain, increasing ATP production and improving cellular energy metabolism. Mitochondrial dysfunction has been identified in 5–30% of individuals with ASD, and is associated with fatigue, regression, and behavioural variability.

850nm near-infrared light penetrates deeper into tissue — including through the skull to reach cortical brain tissue (transcranial PBM). At this depth, it reduces the chronic low-level neuroinflammation documented in post-mortem ASD studies and neuroimaging research. It also reduces reactive oxygen species (ROS), the primary driver of oxidative stress in the ASD brain.

Emerging clinical research, including work from Harvard Medical School's Wellman Center for Photomedicine, supports the use of transcranial near-infrared light for neurological conditions. The Leredd clinic applies full-body photobiomodulation protocols — cranial and abdominal — developed from this research base.

Why It Works

Six Ways Red Light Therapy Supports Autism

Each mechanism is grounded in peer-reviewed research on ASD biology and photobiomodulation. These are not isolated effects — they are interconnected pathways that compound over weeks of consistent daily sessions.

Mitochondrial Energy Support

660nm red light stimulates cytochrome c oxidase — the key enzyme in mitochondrial ATP production. Mitochondrial dysfunction is documented in 5–30% of individuals with ASD and is linked to fatigue, regression, and behavioural variability. Red light therapy addresses this directly at the cellular level.

Neuroinflammation Reduction

850nm near-infrared penetrates skull bone to reach brain tissue (transcranial PBM). At this depth, it reduces chronic low-level neuroinflammation — one of the most consistently documented findings in the ASD brain across post-mortem and neuroimaging studies.

Improved Sleep Quality

Sleep disturbances affect 50–80% of people with ASD. Red light therapy supports melatonin production and circadian rhythm regulation. Many families report measurable improvements in sleep onset and duration within 3–6 weeks of consistent daily sessions.

Reduced Oxidative Stress

Oxidative stress — an imbalance between free radical production and antioxidant defence — is elevated in ASD and is associated with neurological and behavioural symptoms. Red and near-infrared wavelengths reduce reactive oxygen species (ROS) at the cellular level.

Gut-Brain Axis Support

Gastrointestinal issues affect up to 70% of autistic individuals. Abdominal PBM sessions — delivering 660nm + 850nm to the gut — reduce intestinal inflammation and support the gut-brain pathway increasingly linked to autism symptom expression.

Calmer Nervous System

Near-infrared light has been shown to modulate vagal tone and reduce sympathetic nervous system activation. For individuals with ASD who experience heightened sensory reactivity, regular sessions may support a calmer physiological baseline.

How It's Used

The Leredd Autism Protocol

Red light therapy for autism is not a single-zone treatment. An effective protocol combines cranial (transcranial PBM) and abdominal (gut-brain) exposure, delivered daily for 8–12 weeks.

Step 0Step 01

Full Body Session

At the Leredd Melbourne clinic, sessions use full-body MitoCharge panels delivering 660nm + 850nm across the entire body simultaneously. At home, a combination of a face or body panel for cranial and abdominal coverage replicates the clinical protocol.

↗ 15–20 min daily sessions recommended
Step 0Step 02

Transcranial Exposure

Near-infrared at 850nm penetrates the skull to reach cortical tissue — this is transcranial photobiomodulation (tPBM). Panels positioned at the head deliver this directly. Non-invasive, no UV exposure, no discomfort. Safe for daily use.

↗ Keep eyes closed during cranial exposure
Step 0Step 03

Abdominal Coverage

Because of the gut-brain connection in ASD, abdominal sessions are a key part of the protocol. 660nm + 850nm delivered to the abdomen targets intestinal inflammation and supports the microbiome. 10–15 minutes per session is sufficient.

↗ Combine cranial + abdominal for full protocol
Step 0Step 04

Consistent Daily Use

Photobiomodulation is cumulative — the neurological and anti-inflammatory benefits build over weeks. Clinical protocols for autism typically run 5–7 sessions per week for 8–12 weeks before outcomes are formally assessed. Daily home use is the most cost-effective path.

↗ 8–12 weeks for measurable change
Melbourne Clinic

Red Light Therapy for Autism Near Me — Book at Our Melbourne Clinic

If you're searching for red light therapy for autism near me, Leredd's Bentleigh clinic offers full-body MitoCharge panel sessions administered by a qualified photo-therapist. Sessions can be tailored to autism-specific protocols — cranial, abdominal, or full body.

Leredd Light Therapy Clinic — Bentleigh

Address: "BloomSuites" Level 1, 99 Brewer Road, Bentleigh VIC 3204

Area: 15 min from Melbourne CBD · 8 min walk from Patterson Station (Frankston line)

Phone: 0480 839 388

Book a Clinic Session

Not in Melbourne? We Ship Australia-Wide.

All Leredd devices ship free Australia-wide on orders over $99. Our team offers free Zoom consultations to help you build the right at-home protocol for autism — device selection, session structure, and frequency all tailored to your needs.

Common Questions

Red Light Therapy for Autism — FAQ

What is red light therapy for autism?
Red light therapy (photobiomodulation, or PBM) uses specific wavelengths of light — typically 660nm red and 850nm near-infrared — to stimulate cellular function without heat or UV. For autism spectrum disorder (ASD), research focuses on three mechanisms: improving mitochondrial energy production (ATP), reducing neuroinflammation in the brain, and lowering oxidative stress. These are all documented features of ASD biology. PBM is non-invasive, drug-free, and safe for daily use in adults and children.
Is there clinical research supporting red light therapy for autism?
Yes, though it remains an emerging field. Key areas of supporting research include: transcranial photobiomodulation (tPBM) for neurological function (Hamblin, Harvard Medical School); mitochondrial dysfunction in ASD and the role of cytochrome c oxidase stimulation; neuroinflammation in ASD (documented in multiple post-mortem and neuroimaging studies); and gut-brain axis inflammation in ASD. The Leredd clinic applies protocols developed from this body of research. We recommend discussing PBM with your treating clinician, neurologist, or developmental paediatrician as part of an integrated approach.
Is red light therapy safe for children with autism?
Red and near-infrared light therapy at clinical wavelengths (660nm, 850nm) is non-ionising, non-thermal, and produces no UV radiation. It is considered safe for children when used at appropriate parameters. The main precautions are: avoid direct eye exposure (keep eyes closed or use protective eyewear), do not use over known active malignancies, and consult your treating clinician before starting if your child is on photosensitising medications. All Leredd devices are TGA-listed for therapeutic use in Australia.
How is red light therapy for autism delivered — clinic or at home?
Both options are available through Leredd. At our Melbourne clinic in Bentleigh, full-body MitoCharge panel sessions are administered by a qualified photo-therapist — ideal for trialling the therapy and establishing the right protocol. At-home devices (Biohax panels, SUPER-B blankets) allow daily sessions without clinic visits. For autism protocols, a combination of cranial (head/face) and abdominal (gut) exposure is recommended. Our team can advise the right device combination for your specific goals during a free Zoom consultation.
What red light therapy devices does Leredd recommend for autism?
For a full autism protocol covering both transcranial (head) and abdominal (gut-brain) exposure, we recommend: (1) A Biohax M3 panel for cranial and abdominal coverage — high-powered, dual-wavelength, clinical output; (2) The SUPER-B Half Size blanket for full lower body coverage in a single session. For families starting out, a Biohax Desktop 60 provides a compact, high-irradiance option for targeted sessions. Contact us for a personalised device recommendation based on your family's needs and budget.
How long before we see results from red light therapy for autism?
PBM is cumulative — results build over weeks of consistent daily use. Based on clinical protocols and our client experience: sleep improvements are often noticed within 2–4 weeks. Behavioural and regulation changes typically emerge at 6–10 weeks with daily sessions. Full assessment is best done at 12 weeks of consistent daily use. Individual responses vary significantly. We recommend tracking sleep, regulation, and GI symptoms weekly to monitor changes objectively.
Does red light therapy help autism symptoms?
Emerging research suggests red light therapy (photobiomodulation) may support several biological features associated with autism — including mitochondrial dysfunction, neuroinflammation, and oxidative stress — all of which are documented in ASD. Transcranial near-infrared light (850nm) in particular is being studied for its effects on cortical function and neurological wellbeing. PBM is not a cure or medical treatment for autism. It is a non-invasive complementary approach that some families and clinicians include as part of a broader support plan. We recommend discussing it with your treating clinician or developmental paediatrician.
What wavelength of red light is used for autism?
Autism-specific photobiomodulation protocols typically use two wavelengths: 660nm red light for surface cellular energy and mitochondrial support, and 850nm near-infrared for deeper tissue and transcranial (brain) penetration. 850nm is the key wavelength for transcranial PBM — it penetrates the skull to reach cortical brain tissue, where it reduces neuroinflammation and supports cellular metabolism. All Leredd devices emit both wavelengths simultaneously. For autism protocols, we recommend panels that deliver both 660nm and 850nm at clinical irradiance — such as the Biohax M3 or SUPER-B panels.

Start the Protocol — Clinic or At Home.

TGA-listed devices. Free Zoom consultation. Ships Australia-wide. Same-day dispatch from Melbourne.

Shop Devices